Whilst pharmaceutical companies work their magic to make medicines that cure or manage diseases, and the biotechnology industry harnesses cellular and biomolecular processes to develop technologies and products that help improve our lives and the health of our planet. We, at Alfa Laval believe in creating better everyday conditions for the Pharma & Biotech industry so together, we can help even more people towards a healthier and happier life. In 1879, Gustaf de Laval demonstrated the world’s first separator in Stockholm. This in turn was the beginning of Alfa Laval, as we know it today. In 1888 we sold our first pump. This was the beginning of the development of a range of products designed to support the process of fluid handling, our pumps are part of a wide range of products delivering sustainable performance to the pharma and biotech industry, which in turn contributes to global health and well-being. In 1938, we built our first heat exchanger, aiming to improve energy efficiency and lowering the need for fossil fuels. As the world’s demand for energy continues to increase, Alfa Laval continues to develop heat exchangers that are more efficient than alternative technologies, reducing costs, and carbon emissions. For over a century, innovation has been in Alfa Laval’s DNA, looking to the future, we want to continue to innovate for the benefit of the biotech and pharma industry, their customers and society as a whole. Our innovative approach to fluid handling technology including installation material, pumps, valves and tank equipment reduces the risk of contamination, improves safety and reliability whilst delivering a higher yield and more up time. Our heat transfer technology makes our heat exchangers uniquely efficient with much smaller footprints they’re easy to install, their smaller surface area also makes them much easier to clean minimising the microbial content in Pharma and Biotech processing. Our separator technology is widely accepted as state of the art within the biotech and pharma industry the majority of the biotech industry today already uses one of our gentle Alfa Laval separators in their harvest and recovery process. With Alfa Laval as your pharma and biotech partner, your profits are increased we can deliver up to 50% energy saving by optimising centrifugal pump selection with the Alfa Laval LKH UltraPure its external shaft seal ensures your product stays contamination free, while the high flow in the smallest of corners secures product integrity. We can support with up to 90% reduction in cleaning liquid and waste water with refined tank cleaning and up to 70% reduction in cleaning time, together with a minimised risk of microbial contamination. Using the Alfa Laval SaniJet, with its strong impact jets covering the entire interior tank surface, we ensure perfect cleaning action even in the most difficult to clean areas. With Alfa Laval as your partner your yield is increased, our mixing technologies provide a gentle product treatment producing a better homogeneity which in turn delivers a higher yield from bioreactors. The Alfa Laval LeviMag UltraPure magnetic mixer with its efficient impeller design secures efficient mixing whilst ensuring low impact on your product. Our positive displacement pumps gently transport mammalian cells between process steps, reducing cell destruction by up to 50%. The Alfa Laval SX UltraPure rotary lobe pump with its multilobe rotors provides low shear characteristics for sensitive products. and finally, and most importantly, your quality is increased. our Alfa Laval Q-doc documentation package gives you peace of mind with full control guaranteeing the safety and quality of our equipment and your product. Every day, we deliver more than 15,000 fluid handling components to our customers, we have more than 30 000 employees, sales representatives and service partners, in over 35 countries, ready to support and serve you, within the biotech and pharma industry, so you can focus on improving the lives of many more people all around the world.